Takahashi Ryosuke, Kajita Yukihiro, Iwahori Yusuke, Harada Yohei
Department of Orthopaedic Surgery, Ichinomiya Nishi Hospital, Japan.
Department of Orthopaedic Surgery, Asahi Hospital, Japan.
Asia Pac J Sports Med Arthrosc Rehabil Technol. 2022 Oct 5;30:21-24. doi: 10.1016/j.asmart.2022.09.004. eCollection 2022 Oct.
The clinical outcomes of diabetic patients who underwent arthroscopic rotator cuff repair have been reported. However, few studies have focused on the relationship between these clinical outcomes and postoperative hemoglobin A1c. This study compared clinical outcomes of diabetic patients with a hemoglobin A1c < 7% to those with a hemoglobin A1c ≥ 7% at 12 months post-arthroscopic rotator cuff repair.
This retrospective study involved 51 consecutive patients who underwent arthroscopic rotator cuff repair from 2015 to 2020. Approximately 26 and 25 shoulders were assigned to a Low group (hemoglobin A1c < 7%) and High group (hemoglobin A1c ≥ 7%) at 12 months postoperatively, respectively. Patients with poorly controlled diabetes were preoperatively hospitalized for perioperative diabetic control. Clinical outcomes were shoulder range-of-motion, Constant Shoulder Score, and University of California, Los Angeles Score preoperatively and at 12 months postoperatively. Complications were also evaluated.
Both groups showed significant improvement in their range-of-motion, Constant Shoulder Score, and University of California, Los Angeles score at 12 months post-arthroscopic rotator cuff repair (p < 0.05) except external rotation in High group. These improvements were significantly inferior in the High group compared to the Low group (Low/High group; 167.3 ± 7.7°/159.5 ± 16.3° for forward flexion; p = 0.013, 94.9 ± 7.6/90.1 ± 9.9 points for Constant Shoulder Score; p = 0.033, 32.6 ± 3.6/30.6 ± 4.1 points for University of California, Los Angeles score, p = 0.037). Hemoglobin A1c at 12 months postoperatively was also significantly inferior in the High group (Low/High group; 6.5 ± 0.3%/7.6 ± 0.8%; p < 0.05). The rate of rotator cuff retear was not significantly different between groups (Sugaya type4; p = 0.49, type5; p = 0.322) and there were no cases of infection or shoulder stiffness in either group.
Diabetic patients showed improvement of their range-of-motion and function after arthroscopic rotator cuff repair; however, patients with poorly controlled diabetes had significantly inferior improvement.
已报道了接受关节镜下肩袖修复术的糖尿病患者的临床结局。然而,很少有研究关注这些临床结局与术后糖化血红蛋白之间的关系。本研究比较了关节镜下肩袖修复术后12个月时糖化血红蛋白<7%的糖尿病患者与糖化血红蛋白≥7%的糖尿病患者的临床结局。
这项回顾性研究纳入了2015年至2020年连续接受关节镜下肩袖修复术的51例患者。术后12个月时,分别约有26例和25例肩部被分配至低组(糖化血红蛋白<7%)和高组(糖化血红蛋白≥7%)。糖尿病控制不佳的患者术前住院以进行围手术期糖尿病控制。临床结局指标为术前及术后12个月时的肩关节活动范围、Constant肩关节评分和加州大学洛杉矶分校评分。同时对并发症进行评估。
关节镜下肩袖修复术后12个月时,两组患者的肩关节活动范围、Constant肩关节评分和加州大学洛杉矶分校评分均有显著改善(p<0.05),高组除外旋外。与低组相比,高组的这些改善明显较差(低组/高组;前屈角度为167.3±7.7°/159.5±16.3°;p=0.013,Constant肩关节评分为94.9±7.6/90.1±9.9分;p=0.033,加州大学洛杉矶分校评分为32.6±3.6/30.6±4.1分,p=0.037)。术后12个月时高组的糖化血红蛋白水平也明显较差(低组/高组;6.5±0.3%/7.6±0.8%;p<0.05)。两组间肩袖再次撕裂的发生率无显著差异(Sugaya 4型;p=0.49,5型;p=0.322),两组均无感染或肩关节僵硬病例。
糖尿病患者在关节镜下肩袖修复术后肩关节活动范围和功能有所改善;然而,糖尿病控制不佳的患者改善明显较差。